EUCTR2019-000063-24-FR进行中（未招募）1 期
A Study to Evaluate the Safety, Tolerability, and Effect of Risperidone Extended-Release Injectable Suspension (TV-46000) for Subcutaneous Use as Maintenance Treatment in Adult and Adolescent Patients with Schizophrenia
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Roll over patients:
- •The patient must have participated in the pivotal efficacy study (Study TV46000-CNS-30072) without experiencing relapse events and without important protocol deviations.
- •New Patients:
- •The patient has a diagnosis of schizophrenia according to the DSM-5 for >1 year (diagnosis must be reconfirmed by SCID-5) and =1 episode of relapse in the last 24 months.
- •please refer to the protocol for additional inclusion criteria
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 40
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 300
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Roll Over and New patients:
- •The patient has a current clinically significant DSM-5 diagnosis other than schizophrenia, including schizoaffective disorder, major depressive disorder, bipolar disorder, delirium, dementia, or amnestic or other cognitive disorders, or borderline,
- •paranoid, histrionic, schizotypal, schizoid, or antisocial personality disorder.
- •please refer to the protocol for additional exclusion criteria.
研究者
相似试验
已完成
不适用
A Study to Evaluate the Safety, Tolerability, and Effects on NSAID-Induced Small Bowel Pathology of K-196 in Healthy Volunteers.Inflammatory bowel disease (IBD)10017969NL-OMON51579Kallyope, Inc.70
进行中（未招募）
1 期
A Study to Test if TV-46000 is Safe for Maintenance Treatment of SchizophreniaEUCTR2019-000063-24-BGTeva Branded Pharmaceutical Products R&D, Inc.340
尚未招募
1 期
A study to evaluate safety, tolerability and pharmacokinetics of ELVN-001 in Normal Healthy Participants- Part AChronic Myeloid Leukaemia (CML)Parkinson's Disease (PD)Cancer - Leukaemia - Chronic leukaemiaNeurological - Parkinson's diseaseACTRN12624000115538Enliven Therapeutics, Inc.15
尚未招募
1 期
A study to evaluate safety, tolerability and pharmacokinetics of ELVN-001 in Normal Healthy Participants- Part BChronic Myeloid Leukaemia (CML)Parkinson's Disease (PD)Cancer - Leukaemia - Chronic leukaemiaNeurological - Parkinson's diseaseACTRN12624000116527Enliven Therapeutics, Inc.15
已完成
2 期
Study to Evaluate the Safety, Tolerability and Immunogenicity of INO-4700 for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Healthy VolunteersA (Healthy Volunteers)Healthy CoronavirusY59.9LBCTR2020113522Inovio Pharmaceuticals, Inc.542